Literature DB >> 8448079

Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 2.

H Gurney1, D Dodwell, N Thatcher, M H Tattersall.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8448079     DOI: 10.1093/oxfordjournals.annonc.a058411

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  Colony-stimulating factors for the management of neutropenia in cancer patients.

Authors:  David C Dale
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig model.

Authors:  Pierre-Benoit Pagès; Olivier Facy; Pierre Mordant; Sylvain Ladoire; Guy Magnin; Francois Lokiec; Francois Ghiringhelli; Alain Bernard
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

4.  A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients.

Authors:  R de Wit; W H Kruit; C H Lamers; M B van 't Veer; A A Luyten; V van Beurden; M Harteveld; A S Planting; P I Schmitz; G Stoter; R L Bolhuis; J Verweij
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

5.  Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.

Authors:  A Ardizzoni; M C Pennucci; M Danova; C Viscoli; G L Mariani; G Giorgi; M Venturini; C Mereu; T Scolaro; R Rosso
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.